COMMUNIQUÉS West-GlobeNewswire

Novel Augmented Reality Surgery Technology Comes to Hamilton Operating Room
22/01/2019
Mariner Endosurgery's LaparoGuard System Lands at Hamilton General Hospital Hamilton, ON, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Mariner Endosurgery, an innovative Canadian medical device company leading commercialization of [...]
Misonix to Report Fiscal 2019 Second Quarter Financial Results and Host Conference Call and Webcast on February 6
22/01/2019
FARMINGDALE, N.Y., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Oncology Startup Notable Labs Donates its First Pediatric Therapy to Repurposing Non-Profit
22/01/2019
Notable Labs is donating commercial rights to price, manufacture and distribute pediatric leukemia drug to non-profit Cures Within Reach FOSTER CITY, Calif., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Notable Labs , a startup [...]
Generex Biotechnology Provides 2018 Year-End Summary & 2019 Plans
22/01/2019
Acquisitions, Financing, Expansion Initiatives & Strategic Plans MIRAMAR, FL, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www. [...]
RadioMedix received $2.0 M SBIR Phase II Contract award from NCI NIH for the targeted alpha-emitter therapy of neuroendocrine cancers.
22/01/2019
Houston (TX), Jan. 22, 2019 (GLOBE NEWSWIRE) -- RadioMedix Inc. is pleased to announce that the company has been awarded a two-years, $2.0 M Phase II SBIR contract award by the NIH NCI (HHSN261201800048C; UPIID: [...]
Outlook Therapeutics Announces Exercise Price Reduction and Term Extension of Series A Warrants
22/01/2019
CRANBURY, N.J., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK, OTLKW) (the “Company”) today announced that its publicly traded Series A warrants (Nasdaq: OTLKW) have been amended to lower [...]
First Line of Yoga-Centric Supplements Launches in Canada
22/01/2019
Toronto-based entrepreneur introduces Niyama™ Yoga Wellness to support the yoga lifestyle TORONTO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- The practice of yoga gives its students many benefits – from a calmer mind, to a [...]
Naboso™ Technology Expands Product Line to include the First Commercially Available Textured Insoles and Mats designed to Improve Posture, Balance and Strength through Stimulation of the Feet
22/01/2019
Patent-pending texture used in Naboso™ insoles and mats stimulates the nervous system through skin on the bottom of the feet, helping to benefit professional athletes and those with chronic neurological disorders like [...]
Editas Medicine Announces Chief Executive Officer Transition
22/01/2019
Katrine Bosley to Step Down as President and CEO Director Cynthia Collins to Serve as Interim CEO Board of Directors Initiates Search for Permanent Successor CAMBRIDGE, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Editas [...]
CV Sciences, Inc. Announces the Retirement of Its Founder and Management Restructure
22/01/2019
LAS VEGAS, Jan. 22, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that Michael Mona, Jr., the Company’s Founder and former President and Chief [...]
BrainStorm Granted Additional Patent for NurOwn® in Israel
22/01/2019
NEW YORK, Jan. 22, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for debilitating neurodegenerative diseases, today announced [...]
Yield10 Bioscience Initiates Early Development Program in Corn to Evaluate Novel Traits
22/01/2019
WOBURN, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, [...]
TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular Carcinoma
22/01/2019
Three Confirmed Partial Responses (20%) by RECIST and > 50% Reductions of Alpha Fetoprotein in Half of Patients Treated to Date with Combination of TRC105 and Nexavar® Data Presented at ASCO 2019 Gastrointestinal [...]
Producing Supreme Cannabis At Scale -- CFN Media
22/01/2019
SEATTLE, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Albireo Granted Orphan Drug Designation by FDA For Lead Product Candidate A4250 for Treatment of Biliary Atresia
22/01/2019
Expands A4250 development potential in rare cholestatic liver diseases Biliary atresia is among the most common rare pediatric liver diseases and is the most common pediatric liver disease for which transplants are done [...]
CFN Media's Exclusive Interview with Aleafia Health CEO Geoffrey Benic Discussing Emblem Corp. Acquisition
22/01/2019
SEATTLE, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
World’s First Cannabis Validation Testing Program Hits the Market -- CFN Media
22/01/2019
SEATTLE, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Ultragenyx Announces Positive Topline Data from Ongoing Long-Term Extension Study of UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders
22/01/2019
Reductions in Major Clinical Events Sustained After an Additional 78 Weeks of UX007 Treatment Additional 20 Patients Naïve to UX007 Also Demonstrated Meaningful Reductions in Major Clinical Events with Treatment Company [...]
Advantis Corp. Set for Major Expansion in 2019
22/01/2019
Newport Beach, CA, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- ADVANTIS CORPORATION (OTC PINK: ADVT) CEO, Darren Cherry, recently took a moment to reflect on Advantis’ 2018 progress, and provided a look ahead [...]

Pages